• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Optometry Times, Digital Edition, February 2013

Article

Related Videos
Thomas V. Johnson, MD, PhD, of Wilmer Eye Institute discusses his EyeCon 2023 presentation
Mila Ioussifova, OD, FAAO
Related Content
Collarettes on eyelashes indicate Demodex mites and Meibomian Gland Disease which can be treated with lotilaner ophthalmic solution under investigation by Tarsus - Image credit: Adobe Stock /ohishiftl

Topline results from Ersa Phase 2a trial revealed by Tarsus

December 11th 2023
Article
Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care

Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care

October 30th 2023
Podcast
This week in optometry: December 4-December 8

This week in optometry: December 4-December 8

December 9th 2023
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

October 11th 2023
Podcast
microscope looking at slide during cell therapy research - Image credit: Adobe Stock / chokniti

Rapid progress: An update on corneal endothelial cell therapy

December 8th 2023
Article
investigator presents positive results for DAVIO 2 trial - Image credit: Adobe Stock/Coetzee_peopleimages.com

EyePoint Pharmaceuticals unveils favorable topline results from phase 2 DAVIO 2 trial evaluating EYP-1901 in wet AMD

December 7th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.